Development of warm autoimmune hemolytic anemia after initiation of Ruxolitinib in a patient with STAT1 gain-of-function mutation

被引：1
|
作者：
Hartono, Stella [1 ]
Agharahimi, Anahita [2 ]
Tauk, Silpa [3 ]
Bosticardo, Marita [2 ]
Mangat, Mona [4 ]
Pfister, Justina [5 ]
Notarangelo, Luigi [6 ]
Leiding, Jennifer [7 ]
Freeman, Alexandra [6 ]
机构：
[1] NIAID, Bethesda, MD USA
[2] NIH, Bethesda, MD USA
[3] Univ S Florida, Tampa, FL USA
[4] Bay Area Allergy & Asthma, Allergy Immunol, Berkeley, CA USA
[5] NIAID, Primary Immunodeficiency Clin, Bethesda, MD USA
[6] NIAID, NIH, Bethesda, MD USA
[7] Johns Hopkins South Florida, St Petersburg, FL USA
来源：
CLINICAL IMMUNOLOGY | 2023年 / 250卷
关键词：
STAT1; gain-of-function; Ruxolitinib; Autoimmune hemolytic anemia; Sirolimus;
D O I：
10.1016/j.clim.2023.109413
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
66
引用
收藏
页码：29 / 29
页数：1
相关论文
共 50 条
  • [31] Ruxolitinib Response in an Infant With Very-early-onset Inflammatory Bowel Disease and Gain-of-function STAT1 Mutation
    Acker, Karen P.
    Borlack, Rachel
    Iuga, Alina
    Remotti, Helen E.
    Soderquist, Craig R.
    Okada, Satoshi
    Tsumura, Miyuki
    Casanova, Jean-Laurent
    Picoraro, Joseph
    Puel, Anne
    Kinberg, Sivan
    Demirdag, Yesim
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2020, 71 (04): : E132 - E133
  • [32] Stepwise Reversal of Immune Dysregulation Due to STAT1 Gain-of-Function Mutation Following Ruxolitinib Bridge Therapy and Transplantation
    Basak Kayaoglu
    Nurhan Kasap
    Naz Surucu Yilmaz
    Louis Marie Charbonnier
    Busranur Geckin
    Arzu Akcay
    Sevgi Bilgic Eltan
    Gulyuz Ozturk
    Ahmet Ozen
    Elif Karakoc-Aydiner
    Talal A. Chatila
    Mayda Gursel
    Safa Baris
    Journal of Clinical Immunology, 2021, 41 : 769 - 779
  • [33] Is Gain-of-function STAT1 CMC An Interferonopathy?
    Al Shehri, Tariq
    Abinun, Mario
    Gennery, Andrew R.
    Rice, Gillian I.
    Crow, Yanik J.
    Lilic, Desa
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2015, 182 : 15 - 15
  • [34] RUXOLITINIB EFFECTS ON STAT1 GAIN OF FUNCTION MUTATIONS
    Zimmerman, Ofer
    Rosen, Lindsey B.
    Hsu, Amy P.
    Sampaio, Elizabeth P.
    Rosenzweig, Sergio D.
    Zerbe, Christa S.
    Holland, Steven M.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2015, 35 (03) : 327 - 327
  • [35] Hypereosinophilia as a Novel Presenting Feature of STAT1 Gain-of-Function Mutation.
    Norris, Maxwell
    Aktas, Ozge Nur
    Lamborn, Ian
    Fraser, Jamie
    Lin, Adora
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB108 - AB108
  • [36] Rosacea as a striking feature in family members with a STAT1 gain-of-function mutation
    Saez-de-Ocariz, M.
    Suarez-Gutierrez, M.
    Migaud, M.
    O'Farrill-Romanillos
    Casanova, J. L.
    Segura-Mendez, N. H.
    Orozco-Covarrubias, L.
    Espinosa-Padilla, S. E.
    Puel, A.
    Blancas-Galicia, L.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (06) : E265 - E267
  • [37] Interferon signature in patients with STAT1 gain-of-function mutation is epigenetically determined
    Kaleviste, Epp
    Saare, Mario
    Leahy, Timothy Ronan
    Bondet, Vincent
    Duffy, Darragh
    Mogensen, Trine H.
    Jorgensen, Sofie E.
    Nurm, Helke
    Ip, Winnie
    Davies, E. Graham
    Sauer, Sascha
    Syvanen, Ann-Christine
    Milani, Lili
    Peterson, Part
    Kisand, Kai
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 (05) : 790 - 800
  • [38] Jak1/2 inhibitor baricitinib as a potential therapy in a patient with gain-of-function mutation in stat1
    Meesilpavikkai, K.
    Dik, W. A.
    Schrijver, B.
    Nagtzaam, N. M. A.
    Posthumus-van Sluijs, S. J.
    Van Hagen, P. M.
    Dalm, V. A. S. H.
    MEDICAL MYCOLOGY, 2018, 56 : S78 - S78
  • [39] RESISTANT HISTOPLASMOSIS IN A PATIENT WITH A STAT-1 GAIN-OF-FUNCTION MUTATION
    Gao, Y.
    Rosenberg, D.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S159 - S160
  • [40] STAT 1 GAIN OF FUNCTION MUTATION TREATED WITH RUXOLITINIB
    Schussler, E.
    Cunningham-Rundles, C.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S72 - S72
12345